Ojwach, D. B. A.; Madlala, P.; Gordon, M.; Ndung'u, T.; Mann, J. K.: Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design. Virology 554, pp. 1 - 8 (2021)

Tang, M.; Gao, X.; Sun, H.; Tian, S.; Dong, J.; Liu, Z.; Liu, W.: Neutrophil-Lymphocyte Ratio as a Prognostic Parameter in NSCLC Patients Receiving EGFR-TKIs: A Systematic Review and Meta-Analysis. Journal of Oncology 2021 (2021)

Ren, B.; Schmid, M.; Scheiner, M.; Mollenkopf, H.-J.; Lucius, R.; Heitlinger, E.; Gupta, N.: Toxoplasma and Eimeria co-opt the host cFos expression for intracellular development in mammalian cells. Computational and Structural Biotechnology Journal 19 (2021), pp. 719 - 731 (2021)

Dybul, M.; Attoye, T.; Baptiste, S.; Cherutich, P.; Dabis, F.; Deeks, S. G.; Dieffenbach, C.; Doehle, B.; Goodenow, M. M.; Jiang, A. et al.; Kemps, D.; Lewin, S. R.; Lumpkin, M. M.; Mathae, L.; McCune, J. M.; Ndung'u, T.; Nsubuga, M.; Peay, H. L.; Pottage, J.; Warren, M.; Sikazwe: : on behalf the Sunnylands 2019 Working Group, I.: The case for an HIV cure and how to get there. Lancet HIV 8 (1), pp. e51 - e58 (2021)

Lewin, S. R.; Attoye, T.; Bansbach, C.; Doehle, B.; Dubé, K.; Dybul, M.; SenGupta, D.; Jiang, A.; Johnston, R.; Lamplough, R. et al.; McCune, J. M.; Nabel, G. J.; Ndung'u, T.; Pottage, J.; Ripin, D.; Rooney, J. F.; Sikazwe, I.; Nsubuga, M.; Warren, M.; Deeks: on behalf the Sunnylands 2019 Working Group, S. G.: Multi-stakeholder consensus on a target product profile for an HIV cure. Lancet HIV 8 (1), pp. 42 - 50 (2021)

Ziegler, M. C.; Naidoo, K.; Chapel, A.; Nkotwana, S.; Mann, J.; Mncube, Z.; Ismael, N.; Goulder, P.; Ndung'u, T.; Altfeld, M. et al.; Thobakgale, C. F.: HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C∗03:04+ genotype. AIDS 35 (1), pp. 1 - 14 (2021)

Muenchhoff, M.; Chung, A. W.; Roider, J.; Dugast, A.-S.; Richardson, S.; Kløverpris, H.; Leslie, A.; Ndung'u, T.; Moore, P.; Alter, G. et al.; Goulder, P. J. R.: Distinct Immunoglobulin Fc Glycosylation Patterns AreAssociated with Disease Nonprogression and BroadlyNeutralizing Antibody Responses in Children with HIV Infection. mSphere 5 (6), e00880-20, pp. 1 - 16 (2020)

Häcker, B.; Kaufmann, S. H. E.; Bauer, T.; Otto-Knapp, R.: History of BCG Vaccination Recommendations in East and West Germany from 1951 to Date. Pneumologie 74 (12), pp. 811 - 812 (2020)

Wang, D.; Xu, T.; Zhu, H.; Dong, J.; Fu, L.: Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management. American Journal of Cancer Research 10 (12), pp. 4017 - 4037 (2020)

Dekel, N.; Eisenberg-Domovich, Y.; Karlas, A.; Meyer, T. F.; Bracher, F.; Lebendiker, M.; Danieli, T.; Livnah, O.: Expression, purification and crystallization of CLK1 kinase – A potential target for antiviral therapy. Protein Expression and Purification 176, 105742 (2020)

Naidoo, K. K.; Shangase, Z. B.; Rashid, T.; Ngubane, A.; Ismail, N.; Ndung'u, T.; Thobakgale, C. F.: The DARC-null trait is associated with moderate modulation of NK cell profiles and unaltered cytolytic T cell profiles in black South Africans. PLoS One 15 (11), e0242448 (2020)

Bukau, B.; Lanzer, M.; Melchers, F.; Wallon, G.: Hermann Bujard (1934-2020) - pioneering researcher and visionary science politician. EMBO Journal (2020)

Andrade, C. M.; Fleckenstein, H.; Thomson-Luque, R.; Doumbo, S.; Lima, N. F.; Anderson, C.; Hibbert, J.; Hopp, C. S.; Tran, T. M.; Li, S. et al.; Niangaly, M.; Cisse, H.; Doumtabe, D.; Skinner, J.; Sturdevant, D.; Ricklefs, S.; Virtaneva, K.; Asghar, M.; Homann, M. V.; Turner, L.; Martins, J.; Allman, E. L.; N’Dri, M.-E.; Winkler, V.; Llinás, M.; Lavazec, C.; Martens, C.; Färnert, A.; Kayentao, K.; Ongoiba, A.; Lavstsen, T.; Osório, N. S.; Otto, T. D.; Recker, M.; Traore, B.; Crompton, P. D.; Portugal, S.: Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season. Nature Medicine 26, pp. 1929 - 1940 (2020)

Bauer, M.; Nascakova, Z.; Mihai, A.-I.; Cheng, P. F.; Levesque, M. P.; Lampart, S.; Hurwitz, R.; Pfannkuch, L.; Dobrovolna, J.; Jacobs, M. et al.; Bartfeld, S.; Dohlman, A.; Shen, X.; Gall, A. A.; Salama, N. R.; Töpfer, A.; Weber, A.; Meyer, T. F.; Janscak, P.; Müller, A.: The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress. Nature Communications 11 (1), 5117 (2020)

Mann, J. K.; Ndung'u, T.: The potential of lactoferrin, ovotransferrinand lysozyme as antiviral andimmune-modulating agents in COVID-19. Future Virology 15 (9), pp. 609 - 624 (2020)

Cromarty, R.; Sigal, A.; Liebenberg, L. J.; Mckinnon, L. R.; Karim, S. S. A.; Passmore, J.-A. S.; Archary, D.: Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model. Journal of Investigative Medicine 2020, 001424 (2020)

Attaf, M.; Roider, J.; Malik, A.; Rafael, C. R.; Dolton, G.; Predergast, A. J.; Leslie, A.; Ndung'u, T.; Kløverpris, H. N.; Sewell, A. K. et al.; Goulder, P. J.: Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life. FRONTIERS IN IMMUNOLOGY 11, 1587 (2020)

Sepe, L. P.; Hartl, K.; Iftekhar, A.; Berger, H.; Kumar, N.; Goosmann, C.; Chopra, S.; Schmidt, S. C.; Gurumurthy, R. K.; Meyer, T. F. et al.; Boccellato, F.: Genotoxic Effect of Salmonella Paratyphi A Infection on Human Primary Gallbladder Cells. mBio 11 (5), 01911-20. (2020)

Putrianti, E. D.; Schmidt-Christensen, A.; Heussler, V.; Matuschewski, K.; Ingmundson, A.: A Plasmodium cysteine protease required for efficient transition from the liver infection stage. PLOS PATHOGENS 16 (9), 1008891 (2020)

Gibbins, M. P.; Müller, K.; Glover, M.; Liu, J.; Putrianti, E. D.; Bauza, K.; Reyes-Sandoval, A.; Matuschewski, K.; Silvie, O.; Hafalla, J. C. R.: Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection. Infection and Immunity 88 (10), e00383-20 (2020)